Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma

SIMPLE SUMMARY: Rhabdomyosarcoma accounts for more than 50% of all soft tissue sarcomas in childhood and adolescence. Despite intensified multimodality treatment, prognosis is extremely poor, with an overall survival rate of approximately 20% in the advanced stage. Therefore, there is an urgent need...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzhumashev, Dzhangar, Timpanaro, Andrea, Ali, Safa, De Micheli, Andrea J., Mamchaoui, Kamel, Cascone, Ilaria, Rössler, Jochen, Bernasconi, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600270/
https://www.ncbi.nlm.nih.gov/pubmed/36291832
http://dx.doi.org/10.3390/cancers14205048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600270/
https://www.ncbi.nlm.nih.gov/pubmed/36291832
http://dx.doi.org/10.3390/cancers14205048

Ejemplares similares